by Luca Barattini | Feb 6, 2023 | Clinical Trial:, Insights
Panin (Italy) starts two new clinical trial in Europe 06/02/2023 PANIN, an Italian-based pharmaceutical company, announces the starting of two new clinical trials in East Europe handled by Opera CRO. The tested products are vaginal suppositories for vaginal dryness...
by Luca Barattini | Jan 20, 2023 | Clinical Trial:, Insights
SIIT and Opera CRO: 20/01/2023 SIIT, an Italian company manufacturing innovative healthcare products, announced that the planning, execution, and analysis of its new clinical trial in recurrent bacterial vaginosis will be performed by the contract research...
by Luca Barattini | Dec 18, 2022 | Clinical Trial:, Insights
Nausea and vomiting in pregnant women: an Italian survey (PURITY) 18/12/2022 The interim analysis of the survey “Prevalence and burden of nausea and vomiting in pregnant women. An Italian Survey (PURITY)” was presented at the National Congress...
by Luca Barattini | Sep 15, 2022 | Clinical Trial:
Polybactum® to Assess Recurrent Bacterial Vaginosis Study results! 15/09/2022 We are pleased to announce the conclusion of the clinical trial with 10-month follow-up “Polybactum® to Assess Recurrent Bacterial Vaginosis (Polaris)”. The manuscript...
by Luca Barattini | Aug 12, 2022 | Innovation:
Understanding the differences in China’s Regulatory market: 14/02/2023 In this article, you will find a succint overview of 4 different strategies that pharmaceutical companies can apply if they are pursuing the approval of their drug product in China. Although...
